Karlsson Maria, Lutgring Joseph D, Ansari Uzma, Lawsin Adrian, Albrecht Valerie, McAllister Gillian, Daniels Jonathan, Lonsway David, McKay Susannah, Beldavs Zintars, Bower Chris, Dumyati Ghinwa, Gross Annastasia, Jacob Jesse, Janelle Sarah, Kainer Marion A, Lynfield Ruth, Phipps Erin C, Schutz Kyle, Wilson Lucy, Witwer Medora L, Bulens Sandra N, Walters Maroya Spalding, Duffy Nadezhda, Kallen Alexander J, Elkins Christopher A, Rasheed J Kamile
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Oregon Health Authority, Portland, Oregon, USA.
Microb Drug Resist. 2022 Apr;28(4):389-397. doi: 10.1089/mdr.2021.0106. Epub 2022 Feb 16.
Carbapenem-resistant Enterobacterales (CRE) are a growing public health concern due to resistance to multiple antibiotics and potential to cause health care-associated infections with high mortality. Carbapenemase-producing CRE are of particular concern given that carbapenemase-encoding genes often are located on mobile genetic elements that may spread between different organisms and species. In this study, we performed phenotypic and genotypic characterization of CRE collected at eight U.S. sites participating in active population- and laboratory-based surveillance of carbapenem-resistant organisms. Among 421 CRE tested, the majority were isolated from urine ( = 349, 83%). was the most common organism ( = 265, 63%), followed by complex ( = 77, 18%) and ( = 50, 12%). Of 419 isolates analyzed by whole genome sequencing, 307 (73%) harbored a carbapenemase gene; variants of predominated ( = 299, 97%). The occurrence of carbapenemase-producing , complex, and varied by region; the predominant sequence type within each genus was ST258, ST171, and ST131, respectively. None of the carbapenemase-producing CRE isolates displayed resistance to all antimicrobials tested; susceptibility to amikacin and tigecycline was generally retained.
耐碳青霉烯类肠杆菌科细菌(CRE)因对多种抗生素耐药且有可能引发死亡率很高的医疗保健相关感染,日益引起公共卫生关注。鉴于产碳青霉烯酶的CRE中,碳青霉烯酶编码基因通常位于可在不同生物体和物种间传播的移动遗传元件上,这类细菌尤其令人担忧。在本研究中,我们对在美国8个地点收集的CRE进行了表型和基因型特征分析,这些地点参与了基于人群和实验室的耐碳青霉烯类生物体主动监测。在检测的421株CRE中,大多数分离自尿液(n = 349,83%)。大肠埃希菌是最常见的生物体(n = 265,63%),其次是肺炎克雷伯菌复合群(n = 77,18%)和肠杆菌属(n = 50,12%)。在通过全基因组测序分析的419株分离株中,307株(73%)携带碳青霉烯酶基因;blaKPC变体占主导(n = 299,97%)。产碳青霉烯酶的大肠埃希菌、肺炎克雷伯菌复合群和肠杆菌属的发生率因地区而异;每个属内的主要序列类型分别为ST258、ST171和ST131。所有产碳青霉烯酶的CRE分离株均未对所有测试抗菌药物表现出耐药性;对阿米卡星和替加环素的敏感性通常得以保留。